Clinical Trial Update: Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sphenopalatine ganglion block for post-stroke headache has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Stroke

Snippet

Sponsor: University of Utah | Conditions: Headache, Stroke | Phase 2 | Status: WITHDRAWN